Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: effect of 6-hydroxydopamine

DC U'PRICHARD, WD Bechtel, BM ROUOT… - Molecular …, 1979 - ASPET
[ 3 H]Clonidine (26.7 Ci/mmole) binds with high affinity to sites on rat brain membranes with
properties of alpha-noradrenergic receptors. [ 3 H]Clonidine binding shows a biphasic …

Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology

…, M Entzeroth, GB Schiavi, H Ladinsky, WD Bechtel… - Life sciences, 1993 - Elsevier
Clinical trials with muscarinic agonists or acetylcholine esterase inhibitors for the treatment
of Alzheimer's dementia have shown disappointing or equivocal results (1). An alternative …

New tetracyclic guanidine derivatives with H1-antihistaminic properties. Chemistry of epinastine.

G Walther, H Daniel, WD Bechtel, K Brandt - Arzneimittel-forschung, 1990 - europepmc.org
A series of new tetracyclic guanidines were synthesized by various methods. Specific binding
of the described compounds to histamine-1 and histamine-2 receptors was determined. …

Pharmacokinetics and metabolism of brotizolam in humans.

WD Bechtel - British journal of clinical pharmacology, 1983 - Wiley Online Library
… In humans, numerous pharmacokinetic single dose (Bechtel et al., unpublished observations),
increasing dose and multiple dose studies have been carried out (Bechtel et al., in …

Potent blockade of sodium channels and protection of brain tissue from ischemia by BIII 890 CL

…, M Grauert, U Pschorn, WD Bechtel… - Proceedings of the …, 2000 - National Acad Sciences
We have synthesized a new benzomorphan derivative, 2R-[2α,3(S*),6α]-1,2,3,4,5,6-hexahydro-6,11,11-trimethyl-3-[2-(phenylmethoxy)propyl]-2,6-methano-3-benzazocin-10-ol …

In vitro and in vivo studies of the non-sedating antihistamine epinastine.

A Fügner, WD Bechtel, FJ Kuhn, J Mierau - Arzneimittel-forschung, 1988 - europepmc.org
Epinastine (3-amino-9, 13b-dihydro-1H-dibenz [c, f] imidazo [1, 5-a] azepine hydrochloride,
WAL 801 CL) was tested in vitro and in vivo in comparison with other H1-receptor antagonists…

WAL 2014 FU (Talsaclidine): A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease

HA Ensinger, WD Bechtel, FW Birke… - Drug development …, 1997 - Wiley Online Library
The functional selectivity of WAL 2014 FU with regard to stimulation of the neuronal
muscarinic M1 receptor subtype in vitro and in vivo is shown in different receptor preparations, …

Synthesis and Structure− Activity Relationships of 6, 7-Benzomorphan Derivatives as Antagonists of the NMDA Receptor− Channel Complex

M Grauert, WD Bechtel, HA Ensinger… - Journal of medicinal …, 1997 - ACS Publications
We have synthesized a series of stereoisomeric 6,7-benzomorphan derivatives with modified
N-substituents and determined their ability to antagonize the N-methyl-d-aspartate (NMDA) …

BIIR 561 CL: A novel combined antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with …

T Weiser, M Brenner, R Palluk, WD Bechtel… - … of Pharmacology and …, 1999 - ASPET
Antagonists of glutamate receptors of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic
acid (AMPA) subtype, as well as of voltage-gated sodium channels, exhibit anticonvulsive …

Synthesis and antidepressant activity of 4-aryltetrahydrothieno [2, 3-c] pyridine derivatives

…, KH Weber, H Daniel, WD Bechtel… - Journal of medicinal …, 1984 - ACS Publications
A series of substituted 4-aryltetrahydrothieno [2, 3-c] pyridines was prepared by acid-catalyzed
cyclization of 1-aryl-2-[(2-thienylmethyl) amino] ethanol derivatives. The compounds were …